12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity continued to decline, with no pricings for the first week ever in 2021 and just four new filings.
The largest deal...read more
Treace Medical Concepts, which makes a medical device system for the treatment of bunions, raised $191 million by offering 11.3 million shares (44% secondary) at $17, the high end of the range of $15 to $17. The selling shareholders sold 1.9 million more secondary shares than anticipated. At pricing, the company commands a fully diluted market value of $995 million. ...read more
Treace Medical Concepts, which makes a medical device system for the treatment of bunions, announced terms for its IPO on Monday. The Ponte Vedra, FL-based company plans to raise $150 million by offering 9.4 million shares (33% insider) at a price range of $15 to $17. At the midpoint of the proposed range, Treace Medical Concepts would command a fully diluted market value of...read more
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million at a $26.0 billion market cap. The company provides software that identifies automation opportunities across organizations....read more
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
US IPO Weekly Recap: UiPath’s billion-dollar deal leads a 12 IPO Week
12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity continued to decline, with no pricings for the first week ever in 2021 and just four new filings. The largest deal...read more
Bunion medical device maker Treace Medical Concepts prices upsized IPO at $17 high end
Treace Medical Concepts, which makes a medical device system for the treatment of bunions, raised $191 million by offering 11.3 million shares (44% secondary) at $17, the high end of the range of $15 to $17. The selling shareholders sold 1.9 million more secondary shares than anticipated. At pricing, the company commands a fully diluted market value of $995 million. ...read more
Bunion medical device maker Treace Medical Concepts sets terms for $150 million IPO
Treace Medical Concepts, which makes a medical device system for the treatment of bunions, announced terms for its IPO on Monday. The Ponte Vedra, FL-based company plans to raise $150 million by offering 9.4 million shares (33% insider) at a price range of $15 to $17. At the midpoint of the proposed range, Treace Medical Concepts would command a fully diluted market value of...read more
US IPO Week Ahead: Software, synthetic biology, and more in an 11 IPO week
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million at a $26.0 billion market cap. The company provides software that identifies automation opportunities across organizations....read more